{"id":4654,"date":"2023-07-16T15:12:58","date_gmt":"2023-07-16T15:12:58","guid":{"rendered":"https:\/\/wapcpharm.org\/journal\/?p=4654"},"modified":"2023-07-28T15:18:52","modified_gmt":"2023-07-28T15:18:52","slug":"west-african-journal-of-pharmacy-2017-28-2-143-149","status":"publish","type":"post","link":"https:\/\/wapcpharm.org\/journal\/west-african-journal-of-pharmacy-2017-28-2-143-149\/","title":{"rendered":"West African Journal of Pharmacy (2017) 28 (2) 143-149"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"4654\" class=\"elementor elementor-4654\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-43addb94 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"43addb94\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-3d31142b\" data-id=\"3d31142b\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-5304e4af elementor-widget elementor-widget-text-editor\" data-id=\"5304e4af\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p style=\"text-align: center;\"><b>Short Communication<\/b><\/p><p style=\"text-align: center;\"><b>\u00a0<\/b><\/p><p style=\"text-align: center;\"><b>Effect of diclofenac and paracetamol on anticonvulsant activity of phenytoin and sodium\u00a0<\/b><b style=\"font-size: 19px; color: var( --e-global-color-text );\">valproate in laboratory animals<\/b><\/p><p style=\"text-align: center;\"><b style=\"font-size: 19px; color: var( --e-global-color-text );\">\u00a0<\/b><\/p><p style=\"text-align: center;\">Jamilu Ya&#8217;u , Sani Malami , Abubakar Yakubu and Joseph A. Anuka<\/p><p style=\"text-align: center;\">1<span style=\"font-size: 19px; color: var( --e-global-color-text );\">Department of Pharmacology and Therapeutics, Ahmadu Bello University, Zaria, Nigeria<\/span><\/p><p style=\"text-align: center;\">2<span style=\"font-size: 19px; color: var( --e-global-color-text );\">Department of Pharmacology and Therapeutics, Bayero University, Kano, Nigeria<\/span><\/p><p style=\"text-align: center;\">\u00a0<\/p><p style=\"text-align: center;\">Corresponding author: Jamilu Ya&#8217;u,<\/p><p style=\"text-align: center;\">\u00a0<\/p><p style=\"text-align: center;\">Email yjamilu@abu.edu.ng Phone +2348032415294<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-2e03aef5 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"2e03aef5\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-31504988\" data-id=\"31504988\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-14e1425b elementor-widget elementor-widget-heading\" data-id=\"14e1425b\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">ABSTRACT<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-17660739 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"17660739\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-5bf3782b\" data-id=\"5bf3782b\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-4d298d57 elementor-widget elementor-widget-text-editor\" data-id=\"4d298d57\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p style=\"text-align: justify;\"><b>Background:<\/b> Neuroinflammation is a major contributor to neurological and neurodegenerative diseases, and&nbsp;<span style=\"font-size: 19px; color: var( --e-global-color-text );\">inflammatory processes have been implicated in both acute and chronic conditions such as epilepsy.&nbsp;<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">Cyclooxygenase (COX) inhibitors, are used largely to treat febrile condition, pain state and inflammation,&nbsp;<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">through their role in the inhibition of prostaglandin synthesis. Thus, drugs that reduce the production of&nbsp;<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">prostaglandins may have beneficial effect in epilepsy.<\/span><\/p><p style=\"text-align: justify;\"><b>Objective:<\/b> The present study is aimed at evaluating possible effects of diclofenac and paracetamol on the&nbsp;<span style=\"font-size: 19px; color: var( --e-global-color-text );\">anticonvulsant outcome of phenytoin and sodium valproate in chicks and mice.<\/span><\/p><p style=\"text-align: justify;\"><b>Methods:<\/b> Electrically and chemically-induced seizure models, using maximal electroshock test (MEST) in&nbsp;<span style=\"font-size: 19px; color: var( --e-global-color-text );\">chicks and pentylenetetrazole (PTZ) test in mice, respectively, were used for the study.<\/span><\/p><p style=\"text-align: justify;\">R<b>esults:<\/b> Co-administration (i.p.) of diclofenac (20 mg\/kg) and paracetamol (100 mg\/kg), each with phenytoin&nbsp;<span style=\"font-size: 19px; color: var( --e-global-color-text );\">(15 mg\/kg, i.p.), potentiated the anticonvulsant outcome of phenytoin in MEST. Diclofenac-phenytoin and&nbsp;<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">paracetamol-phenytoin administrations exhibited 90% and 80% protection, respectively, as against the 0%&nbsp;<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">protection produced when diclofenac and paracetamol were administered alone. Similarly, there was&nbsp;<\/span><span style=\"color: var( --e-global-color-text ); font-size: 19px;\">statistical significant decrease (p&lt;0.05) in the recovery time from seizures between the groups co-<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">administered with the two drugs and those that received individual drugs. In PTZ-induced seizure test, there&nbsp;<\/span><span style=\"color: var( --e-global-color-text ); font-size: 19px;\">was slight decrease in seizure protection (60%); with significant increase (p&lt;0.05) in the mean onset of&nbsp;<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">seizures when diclofenac (20 mg\/kg) and sodium valproate (100 mg\/kg) were co-administered; while&nbsp;<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">valproate (100 mg\/kg) exhibited 80% protection with no significant increase (p&lt;0.05) in the mean onset of&nbsp;<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">seizures. Also, similar protection of 80% was obtained when paracetamol (100 mg\/kg) and valproate (100&nbsp;<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">mg\/kg) were co-administered showing no potentiation or antagonism in PTZ-induced seizure test.<\/span><\/p><p style=\"text-align: justify;\"><b>Conclusion:<\/b> The results of this study showed potentiating effect when diclofenac and phenytoin;&nbsp;<span style=\"font-size: 19px; color: var( --e-global-color-text );\">paracetamol and phenytoin, were co-administered. Therefore, the co-administration may be beneficial in&nbsp;<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">generalized tonic-clonic seizures.<\/span><\/p><p style=\"text-align: justify;\"><b>Key words<\/b>: Diclofenac; Paracetamol; Phenytoin; Valproate ; Cyclooxygenase<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5c69195 elementor-align-right elementor-widget elementor-widget-button\" data-id=\"5c69195\" data-element_type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/wapcpharm.org\/journal\/wp-content\/uploads\/2023\/07\/Chapter-14_compressed.pdf\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-text\">Download <\/span>\n\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Short Communication \u00a0 Effect of diclofenac and paracetamol on anticonvulsant activity of phenytoin and sodium\u00a0valproate in laboratory animals \u00a0 Jamilu Ya&#8217;u , Sani Malami , Abubakar Yakubu and Joseph A. Anuka 1Department of Pharmacology and Therapeutics, Ahmadu Bello University, Zaria, Nigeria 2Department of Pharmacology and Therapeutics, Bayero University, Kano, Nigeria \u00a0 Corresponding author: Jamilu Ya&#8217;u, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[233],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/4654"}],"collection":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/comments?post=4654"}],"version-history":[{"count":4,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/4654\/revisions"}],"predecessor-version":[{"id":4660,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/4654\/revisions\/4660"}],"wp:attachment":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/media?parent=4654"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/categories?post=4654"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/tags?post=4654"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}